The Interlaminar Device Market encompasses a diverse range of medical devices designed to support spinal and related surgical procedures. The market was valued at USD 2.2 billion in 2024 and is forecast to reach approximately USD 5 billion by 2035, growing at a CAGR of 7.8% from 2025 to 2035.

By application, the market is divided into spinal surgery, orthopedic surgery, trauma surgery, and neurosurgery. Spinal surgery represents a particularly important application because of the growing need for effective interventions for spinal disorders.

By device type, the industry includes interspinous devices, interlaminar stabilization devices, bone screws, and spacers. These products are designed to provide stabilization, support, and improved surgical outcomes.

The end-use segment includes hospitals, ambulatory surgical centers, and specialty clinics. Hospitals remain important because of their advanced surgical capabilities, while ambulatory centers are gaining attention because they can provide efficient outpatient procedures.

By material, titanium, polyether ether ketone, and stainless steel are major categories. Material innovation continues to influence device development by focusing on strength, durability, compatibility, and clinical performance.

Regionally, North America is expected to dominate because of its established healthcare infrastructure and high healthcare spending. Europe also represents a significant market, while Asia-Pacific is expected to experience strong growth due to increasing healthcare investments.

Key companies participating in the market include Boston Scientific, Smith & Nephew, Stryker, B. Braun Melsungen, Cook Medical, Medtronic, Abbott, Zimmer Biomet, and Johnson & Johnson.